Tech Company Financing Transactions
Microplate Dx Funding Round
Deepbridge Capital, Scottish Enterprise and SIS Ventures participated in a $3.1 million Seed funding round for Microplate Dx. The funding round closed on 9/11/2023.
Transaction Overview
Company Name
Announced On
9/11/2023
Transaction Type
Venture Equity
Amount
$3,097,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to develop its point-of-care diagnostic platform which can confirm the presence of bacteria and guide a patient's doctor to effective treatment by rapidly identifying effective antibiotics to use and which ones to avoid.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Wolfson Centre Room Wc 514 106 Rottenrow
Glasgow, Scotland, G4 0NW
UK
Glasgow, Scotland, G4 0NW
UK
Phone
Undisclosed
Website
Email Address
Overview
Microplate Dx are an award winning spinout company from the University of Strathclyde in Glasgow, specialising in developing novel diagnostic solutions to tackle the major global health threat of antimicrobial resistance. The Microplate Dx technology is based on the simple yet highly innovative concept of using highly sensitive biosensor electrodes, modified with miniaturised hydrogel deposits laden with different antibiotics, depending on the infection type being measured. Microplate Dx exists to prevent and control the spread of antimicrobial resistance worldwide.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/11/2023: Open Cosmos venture capital transaction
Next: 9/11/2023: traide venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs